Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
STAQUIS (Pfizer Australia Pty Ltd)
Product name
STAQUIS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
249 working days (255)
Active ingredients
crisaborole
Registration type
NCE/NBE
Indication
STAQUIS (2% w/w ointment) is indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.